Perceptive Advisors Llc - Insider Trading & Ownership

Entity
Company
Location
51 Astor Place, 10 Th Floor, New York, NY
Summary
The estimated value of insider holdings of Perceptive Advisors Llc is at least $980M dollars as of August 14, 2024. Perceptive Advisors Llc is the 10%+ Owner of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $200M. Perceptive Advisors Llc is the 10%+ Owner of VBI Vaccines Inc/BC and owns shares of VBI Vaccines Inc/BC (VBIVQ) stock worth about $137M. Perceptive Advisors Llc is the 10%+ Owner of SOLENO THERAPEUTICS INC and owns shares of SOLENO THERAPEUTICS INC (SLNO) stock worth about $112M. Perceptive Advisors Llc is the 10%+ Owner of ALBIREO PHARMA, INC. and owns shares of ALBIREO PHARMA, INC. stock worth about $85M. Perceptive Advisors Llc is the Director of Astria Therapeutics, Inc. and owns shares of Astria Therapeutics, Inc. (ATXS) stock worth about $67.2M. Perceptive Advisors Llc is the 10%+ Owner of ADMA BIOLOGICS, INC. and owns shares of ADMA BIOLOGICS, INC. (ADMA) stock worth about $59.9M. Perceptive Advisors Llc is the 10%+ Owner of Verrica Pharmaceuticals Inc. and owns shares of Verrica Pharmaceuticals Inc. (VRCA) stock worth about $51.4M. Perceptive Advisors Llc is the Director, 10%+ Owner of MeiraGTx Holdings plc and owns shares of MeiraGTx Holdings plc (MGTX) stock worth about $50.1M. Perceptive Advisors Llc is the 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $45.6M. Perceptive Advisors Llc is the 10%+ Owner of Aldeyra Therapeutics, Inc. and owns shares of Aldeyra Therapeutics, Inc. (ALDX) stock worth about $44M. Perceptive Advisors Llc is the Director, 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $37.8M. Perceptive Advisors Llc is the Director, 10%+ Owner of Lyra Therapeutics, Inc. and owns shares of Lyra Therapeutics, Inc. (LYRA) stock worth about $34M. Perceptive Advisors Llc is the 10%+ Owner of AGILE THERAPEUTICS INC and owns shares of AGILE THERAPEUTICS INC (AGRX) stock worth about $18.4M. Perceptive Advisors Llc is the Director, 10%+ Owner of Athira Pharma, Inc. and owns shares of Athira Pharma, Inc. (ATHA) stock worth about $12.9M. Perceptive Advisors Llc is the 10%+ Owner of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $11.3M. Perceptive Advisors Llc is the Former 10% Owner of CARGO Therapeutics, Inc. and owns shares of CARGO Therapeutics, Inc. (CRGX) stock worth about $5M. Perceptive Advisors Llc is the 10%+ Owner of Rain Therapeutics Inc. and owns shares of Rain Oncology Inc. stock worth about $3.01M. Perceptive Advisors Llc is the 10%+ Owner of IsoPlexis Corp and owns shares of IsoPlexis Corp stock worth about $2.97M. Perceptive Advisors Llc is the 10%+ Owner of CHEMBIO DIAGNOSTICS, INC. and owns shares of CHEMBIO DIAGNOSTICS, INC. stock worth about $1.65M. Perceptive Advisors Llc is the 10%+ Owner of Quotient Ltd and owns shares of Quotient Ltd stock worth about $636K. Perceptive Advisors Llc is the Director, 10%+ Owner of LianBio and owns shares of LianBio (LIANY) stock worth about $81.3K.
All Insider Reports
All Insider Reports

Ownership of Perceptive Advisors Llc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRNX Crinetics Pharmaceuticals, Inc. 10%+ Owner $200M Apr 18, 2022
VBIVQ VBI Vaccines Inc/BC 10%+ Owner $137M Apr 4, 2023
SLNO SOLENO THERAPEUTICS INC 10%+ Owner $112M Sep 26, 2023
ALBO ALBIREO PHARMA, INC. 10%+ Owner $85M Oct 11, 2022
ATXS Astria Therapeutics, Inc. Director $67.2M +$60.6M +920% Feb 1, 2024
ADMA ADMA BIOLOGICS, INC. 10%+ Owner $59.9M Sep 28, 2021
VRCA Verrica Pharmaceuticals Inc. 10%+ Owner $51.4M +$12.5M +32.1% Dec 27, 2023
MGTX MeiraGTx Holdings plc Director, 10%+ Owner $50.1M +$5M +11.1% Aug 12, 2024
ACRV Acrivon Therapeutics, Inc. 10%+ Owner $45.6M +$20M +78.2% Apr 11, 2024
ALDX Aldeyra Therapeutics, Inc. 10%+ Owner $44M -$1.68M -3.69% Apr 4, 2024
SLDB Solid Biosciences Inc. Director, 10%+ Owner $37.8M +$18.9M +99.6% Jan 11, 2024
LYRA Lyra Therapeutics, Inc. Director, 10%+ Owner $34M May 31, 2023
AGRX, AGXRW AGILE THERAPEUTICS INC 10%+ Owner $18.4M Oct 13, 2021
ATHA Athira Pharma, Inc. Director, 10%+ Owner $12.9M +$1.46M +12.8% Dec 27, 2023
VYNE VYNE Therapeutics Inc. 10%+ Owner $11.3M Aug 16, 2021
CRGX CARGO Therapeutics, Inc. Former 10% Owner $5M Nov 14, 2023
RAIN Rain Oncology Inc. 10%+ Owner $3.01M Oct 7, 2021
ISO IsoPlexis Corp 10%+ Owner $2.97M Oct 12, 2021
CEMI CHEMBIO DIAGNOSTICS, INC. 10%+ Owner $1.65M Apr 4, 2023
QTNT Quotient Ltd 10%+ Owner $636K Oct 31, 2022
LIANY LianBio Director, 10%+ Owner $81.3K Feb 15, 2024
CERE Cerevel Therapeutics Holdings, Inc. Director $0 +$20M Feb 20, 2024
ADGM Adagio Medical Holdings, Inc. Director, 10%+ Owner Jul 31, 2024
LABP Landos Biopharma, Inc. 10%+ Owner Jan 10, 2023
LPTX LEAP THERAPEUTICS, INC. 10%+ Owner Sep 24, 2021
NAUT Nautilus Biotechnology, Inc. Director, 10%+ Owner Jun 14, 2024
OBIO Orchestra BioMed Holdings, Inc. 10%+ Owner Jul 11, 2024
VAPO VAPOTHERM INC 10%+ Owner Jun 17, 2024

Insider Transactions Reported by Perceptive Advisors Llc:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.